Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US-Reference-Cited by-同舟云学术

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US

Published:2023-05-26 Issue:5 Volume:6 Page:e2316089
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Weiner Scott G.¹,Qato Dima M.²,Faust Jeremy Samuel³,Clear Brian¹

Affiliation:

1. Bicycle Health Inc, Boston, Massachusetts

2. Program on Medicines and Public Health, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles

3. Department of Emergency Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

Abstract

This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2805329/weiner_2023_ld_230082_1684340606.96715.pdf

Reference6 articles.

2. Federal and state pharmacy regulations and dispensing barriers to buprenorphine access at retail pharmacies in the US.;Qato;JAMA Health Forum,2022

3. Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study.;Beetham;Ann Intern Med,2019

4. Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.;Frost;JAMA Netw Open,2022

5. Department of Health and Human Services. Practice guidelines for the administration of buprenorphine for treating opioid use disorder. 2021. Accessed April 15, 2023. https://www.govinfo.gov/content/pkg/FR-2021-04-28/pdf/2021-08961.pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing suboxone access in community pharmacies: Secret shopper model;Exploratory Research in Clinical and Social Pharmacy;2023-12

2. Invoking a Medical Axiom for Buprenorphine Initiation—See One, Do One, Teach One;JAMA Network Open;2023-11-10